(Total Views: 504)
Posted On: 01/13/2021 1:34:51 AM
Post# of 155131
Sure phase 4 would be great for more specialized testing.
And if CD12 gets a quick EUA, CYDY will be swimming in cash so they can do these cheap DNA tests very easily and quickly.
The problem is if CD12 deosnt break out.
Then CYDY has cash problems and won't want to do anything extra.
Thats why I am saying recast as genetics with a small number of patients and they can do it quickly.
But even better if CD12 failure is to bring in a partner. The partner will be able to recast to genetics quickly and easily.
It would surprise me if CYDY has not already had partnership discussions for the purpose of moving forward on covid if CD12 does not get EUA.
And if CD12 gets a quick EUA, CYDY will be swimming in cash so they can do these cheap DNA tests very easily and quickly.
The problem is if CD12 deosnt break out.
Then CYDY has cash problems and won't want to do anything extra.
Thats why I am saying recast as genetics with a small number of patients and they can do it quickly.
But even better if CD12 failure is to bring in a partner. The partner will be able to recast to genetics quickly and easily.
It would surprise me if CYDY has not already had partnership discussions for the purpose of moving forward on covid if CD12 does not get EUA.
(0)
(1)
